• Publications
  • Influence
The Banff 97 working classification of renal allograft pathology.
BACKGROUND Standardization of renal allograft biopsy interpretation is necessary to guide therapy and to establish an objective end point for clinical trials. This manuscript describes aExpand
  • 2,897
  • 131
  • PDF
Banff '05 Meeting Report: Differential Diagnosis of Chronic Allograft Injury and Elimination of Chronic Allograft Nephropathy (‘CAN’)
The 8th Banff Conference on Allograft Pathology was held in Edmonton, Canada, 15–21 July 2005. Major outcomes included the elimination of the non‐specific term ‘chronic allograft nephropathy’ (CAN)Expand
  • 1,003
  • 57
  • PDF
Antibody‐Mediated Rejection Criteria – an Addition to the Banff ′97 Classification of Renal Allograft Rejection
Antibody‐mediated rejection (AbAR) is increasingly recognized in the renal allograft population, and successful therapeutic regimens have been developed to prevent and treat AbAR, enabling excellentExpand
  • 966
  • 52
  • PDF
Reduced exposure to calcineurin inhibitors in renal transplantation.
BACKGROUND Immunosuppressive regimens with the fewest possible toxic effects are desirable for transplant recipients. This study evaluated the efficacy and relative toxic effects of fourExpand
  • 1,057
  • 41
  • PDF
Banff ’09 Meeting Report: Antibody Mediated Graft Deterioration and Implementation of Banff Working Groups
The 10th Banff Conference on Allograft Pathology was held in Banff, Canada from August 9 to 14, 2009. A total of 263 transplant clinicians, pathologists, surgeons, immunologists and researchersExpand
  • 683
  • 36
  • PDF
International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology.
A group of renal pathologists, nephrologists, and transplant surgeons met in Banff, Canada on August 2-4, 1991 to develop a schema for international standardization of nomenclature and criteria forExpand
  • 1,312
  • 34
  • PDF
Immunosuppressive drugs for kidney transplantation.
  • P. Halloran
  • Medicine
  • The New England journal of medicine
  • 23 December 2004
Suppression of allograft rejection is central to successful organ transplantation; thus, immunosuppressive agents are crucial for successful allograft function. Immunosuppressive drugs are used forExpand
  • 744
  • 33
  • PDF
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody‐mediated rejection, and prospects for integrative endpoints for
The kidney sessions of the 2017 Banff Conference focused on 2 areas: clinical implications of inflammation in areas of interstitial fibrosis and tubular atrophy (i‐IFTA) and its relationship to TExpand
  • 344
  • 19
  • PDF
Rethinking chronic allograft nephropathy: the concept of accelerated senescence.
Chronic rejection or chronic allograft nephropathy (CAN) is the major cause of failure of kidney transplants other than patient death, and has been extensively reviewed (1‐5). CAN is characterized byExpand
  • 460
  • 18
  • PDF
Banff 2003 Meeting Report: New Diagnostic Insights and Standards
The Seventh Banff Conference on Allograft Pathology was held June 14–18, 2003 in Aberdeen, Scotland representing the latest iteration of the international consensus meeting, which develops worldwideExpand
  • 226
  • 15
  • PDF